An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer’s disease patients in a small early-stage study, …
[Read more...] about “Gantenerumab” could pave way for Alzheimer’s treatment
INSIGHTS
“Alarm clock” gene explains wake-up function of biological clock
Tring Tring.....Wake Up...Its Morning... Mr. V : I didn't set an alarm !!! whose this ??? Ever wondered why you wake up in the morning—even when the alarm …
[Read more...] about “Alarm clock” gene explains wake-up function of biological clock
Genetics behind Schizophrenia Revealed
At least half of schizophrenia patients who have no family history of the disorder harbor de novomutations, according to research published online on Sunday …
Drug Development for Neuropsychiatric Disorders in Current Scenario
According to Dr.Kenneth I. Kaitin of Tufts Center for the study of the Drug Development "Drugs to treat neuropsychiatric disorders have become too risky for big …
[Read more...] about Drug Development for Neuropsychiatric Disorders in Current Scenario
Genetics Analysis May Lead New Treatment for Parkinson’s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder in which mainly nerve cells in the substantia nigra of the brain die. This region is a central area of …
[Read more...] about Genetics Analysis May Lead New Treatment for Parkinson’s Disease